Kamal Masaki to Antihypertensive Agents
This is a "connection" page, showing publications Kamal Masaki has written about Antihypertensive Agents.
Connection Strength
0.284
-
Gelber RP, Ross GW, Petrovitch H, Masaki KH, Launer LJ, White LR. Antihypertensive medication use and risk of cognitive impairment: the Honolulu-Asia Aging Study. Neurology. 2013 Sep 03; 81(10):888-95.
Score: 0.095
-
Launer LJ, Hughes T, Yu B, Masaki K, Petrovitch H, Ross GW, White LR. Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study. Hypertension. 2010 Jun; 55(6):1352-9.
Score: 0.076
-
Peila R, White LR, Masaki K, Petrovitch H, Launer LJ. Reducing the risk of dementia: efficacy of long-term treatment of hypertension. Stroke. 2006 May; 37(5):1165-70.
Score: 0.057
-
Kadowaki S, Kadowaki T, Hozawa A, Fujiyoshi A, Hisamatsu T, Satoh A, Arima H, Tanaka S, Torii S, Kondo K, Kadota A, Masaki K, Okamura T, Ohkubo T, Miura K, Ueshima H. Differences between home blood pressure and strictly measured office blood pressure and their determinants in Japanese men. Hypertens Res. 2021 Jan; 44(1):80-87.
Score: 0.039
-
Stewart R, Xue QL, Masaki K, Petrovitch H, Ross GW, White LR, Launer LJ. Change in blood pressure and incident dementia: a 32-year prospective study. Hypertension. 2009 Aug; 54(2):233-40.
Score: 0.018